Bristol-Myers Squibb (BMY) Misses Q1 EPS by 7c

Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.74, $0.07 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $11.1 billion versus the consensus estimate of $11.11 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of $7.48.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance